TruBridge (TBRG) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
15 Jan, 2026Executive summary
Achieved fourth consecutive quarter with over $20 million in bookings, reflecting strong demand and sales momentum.
Q3 2024 revenue rose to $83.8M from $82.7M year-over-year, with Financial Health revenue up to $54.3M from $46.6M.
Net loss increased to $17.4 million for the nine months, mainly due to higher amortization and interest expense; Q3 GAAP net loss widened to $(9.8)M.
Integration of Viewgol progressing, with over 30% of CBO/EBO customers now supported by the India team; plans to double this by end of 2025.
Leadership changes include the retirement of COO David Dye, elimination of the COO role, and direct reporting of business unit GMs to the CEO.
Financial highlights
Q3 revenue was $83.8 million, up just over 1% year-over-year; excluding divestitures and sunsetting products, revenue grew 9%.
Financial Health revenue (including Viewgol) was $54.3 million, up 17% year-over-year; organic growth (excluding Viewgol) was 5.3%.
Patient Care revenue was $29.6 million, down 18% due to divestitures and product sunsets.
Adjusted EBITDA for Q3 was $13.8 million, up 42% year-over-year; margin expanded to 16.5% from 11.8%.
Net cash from operations for the nine months was $21.8M, up from $13.3M in the prior year.
Outlook and guidance
Q4 revenue expected between $83.5 million-$85.5 million; adjusted EBITDA between $13.5 million-$14.5 million.
Full-year 2024 revenue guidance narrowed to $335 million-$337 million; adjusted EBITDA to $49 million-$50 million, at the high end of previous guidance.
2025 outlook targets mid- to high-single-digit revenue growth and EBITDA margin improvement, aiming for 20% margin by Q3/Q4 2025.
Management expects continued growth in Financial Health through cross-selling and new contracts, with recurring revenue as a key focus.
Margin optimization efforts include organizational realignment, offshore expansion, and automation, though near-term margin pressure is expected from Viewgol integration.
Latest events from TruBridge
- Margin gains, strong recurring revenue, and GAAP profitability marked the year.TBRG
Q4 202531 Mar 2026 - RCM gains and margin expansion offset EHR declines as full-year guidance is reaffirmed.TBRG
Q2 20242 Feb 2026 - RCM growth, offshoring, and analytics drive TruBridge's margin and operational focus.TBRG
Stifel 2024 Cross Sector Insight Conference1 Feb 2026 - Recurring revenue, offshoring, and automation drive growth and margin expansion into 2025.TBRG
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - Margin gains, SaaS shift, and RCM growth drive a strong outlook in rural healthcare.TBRG
KeyBanc Annual Healthcare Forum 202526 Dec 2025 - 2024 revenue $339.2M, EBITDA up, leverage down, 2025 margin and revenue growth expected.TBRG
Q4 202424 Dec 2025 - Key proposals include board declassification, incentive plan expansion, and strong 2024 results.TBRG
Proxy Filing1 Dec 2025 - Shareholders will vote on board declassification, incentive plan expansion, and executive pay.TBRG
Proxy Filing1 Dec 2025 - Key votes include board declassification, director elections, and incentive plan expansion.TBRG
Proxy Filing1 Dec 2025